Murray Dallan (CIK 2022303) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-03-11). Recent activity: Buy SRPT (5,500 shares), Sell SRPT (996 shares), Sell SRPT (2,737 shares), Buy SRPT (8,276 shares), Buy SRPT (17,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-03-11 | Sarepta Therapeutics, Inc. (SRPT) | Chief Customer Officer | Buy | 5,500 | $0 |
| 2025-03-11 | Sarepta Therapeutics, Inc. (SRPT) | Chief Customer Officer | Sell | 996 | $99,729 |
| 2025-03-11 | Sarepta Therapeutics, Inc. (SRPT) | Chief Customer Officer | Sell | 2,737 | $274,056 |
| 2025-03-11 | Sarepta Therapeutics, Inc. (SRPT) | Chief Customer Officer | Buy | 8,276 | $0 |
| 2025-03-10 | Sarepta Therapeutics, Inc. (SRPT) | Chief Customer Officer | Buy | 17,500 | $0 |
| 2025-03-10 | Sarepta Therapeutics, Inc. (SRPT) | Chief Customer Officer | Sell | 549 | $56,931 |
| 2025-03-10 | Sarepta Therapeutics, Inc. (SRPT) | Chief Customer Officer | Sell | 8,613 | $893,168 |
| 2025-03-06 | Sarepta Therapeutics, Inc. (SRPT) | Chief Customer Officer | Sell | 1,685 | $170,758 |
| 2025-03-04 | Sarepta Therapeutics, Inc. (SRPT) | Chief Customer Officer | Sell | 711 | $73,780 |
Source: SEC Form 4 filings · as of 2025-03-11